Skip to main content
Livermore
Livermore
ZHEN

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

Holdings in Q1 2024

Holdings as of Mar 31, 2024, filed May 14, 2024. Long positions only; changes compare share counts with Q4 2023.

Institution overview
Positions
77
+4 vs. Q4 2023
Portfolio value
$615.1M
+$113.5M (+22.6%) vs. Q4 2023
Filed
May 14, 2024
SEC
Holdings of Affinity Asset Advisors, LLC in Q1 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
Rocket Pharmaceuticals, Inc.77313F114*W EXP 09/02/20275,000$22.4K<0.1%00.0%Unchanged–
Cassava Sciences Inc14817C115*W EXP 11/15/20224,200$97.5K<0.1%+24,200New–
AVTXAvalo Therapeutics, Inc.COM NEW10,000$217.5K<0.1%+10,000NewHistory
PASGPassage BIO, Inc.COM264,266$356.8K0.1%+264,266NewHistory
CNTXContext Therapeutics Inc.COM328,817$453.8K0.1%00.0%UnchangedHistory
QTTBQ32 Bio Inc.COM27,777$473.3K0.1%+27,777NewHistory
Immatics N.V.N44445117*W EXP 07/01/202187,204$486.7K0.1%00.0%Unchanged–
PMNProMIS Neurosciences Inc.COM265,958$508.0K0.1%00.0%UnchangedHistory
TECXTectonic Therapeutic, Inc.COM700,000$896.0K0.1%+200,000+40.0%AddedHistory
TVTXTravere Therapeutics, Inc.COM125,000$963.8K0.2%+125,000NewHistory
TRMLTourmaline Bio, Inc.COM50,000$1.15M0.2%−18,081−26.6%ReducedHistory
ZURAZura Bio LtdCLASS A ORD SHS450,009$1.16M0.2%+450,009NewHistory
TNGXTango Therapeutics, Inc.COM150,274$1.19M0.2%−150,000−50.0%ReducedHistory
ARYDARYA Sciences Acquisition Corp IVCL A133,500$1.50M0.2%+133,500NewHistory
BBIOBridgeBio Pharma, Inc.COM50,000$1.55M0.3%−30,000−37.5%ReducedHistory
KZRKezar Life Sciences, Inc.COM1,761,778$1.59M0.3%+1,761,778NewHistory
BSXBoston Scientific CorpStock25,000$1.71M0.3%+25,000NewHistory
WVEWave Life Sciences, Inc.SHS286,585$1.77M0.3%+286,585NewHistory
ALKSAlkermes plc.SHS75,000$2.03M0.3%−281,384−79.0%ReducedHistory
NAMSWNewAmsterdam Pharma Co N.V.*W EXP 11/22/202202,599$2.24M0.4%+65,599+47.9%AddedHistory
RGNXREGENXBIO Inc.COM110,000$2.32M0.4%+110,000NewHistory
BBOTBridgeBio Oncology Therapeutics, Inc.CL A ORD SHS250,000$2.59M0.4%+250,000NewHistory
PTGXProtagonist Therapeutics, IncCOM100,000$2.89M0.5%+100,000NewHistory
TERNTerns Pharmaceuticals, Inc.COM450,000$2.95M0.5%+384,000+581.8%AddedHistory
NXTCNextCure, Inc.COM1,359,037$3.03M0.5%+1,359,037NewHistory
ARWRArrowhead Pharmaceuticals, Inc.COM120,000$3.43M0.6%+120,000NewHistory
ITCIIntra-Cellular Therapies, Inc.COM50,000$3.46M0.6%+50,000NewHistory
IMTXImmatics N.V.SHS350,000$3.68M0.6%+150,000+75.0%AddedHistory
MLTXMoonLake ImmunotherapeuticsCLASS A ORD75,000$3.77M0.6%+4,012+5.7%AddedHistory
MIRMMirum Pharmaceuticals, Inc.COM160,000$4.02M0.7%+110,000+220.0%AddedHistory
RZLTRezolute, Inc.COM NEW1,600,000$4.08M0.7%+1,600,000NewHistory
VKTXViking Therapeutics, Inc.COM50,000$4.10M0.7%−250,000−83.3%ReducedHistory
MLYSMineralys Therapeutics, Inc.COM327,959$4.23M0.7%+327,959NewHistory
CGEMCullinan Therapeutics, Inc.COM258,588$4.41M0.7%−41,412−13.8%ReducedHistory
MRSNMersana Therapeutics, Inc.COM1,000,000$4.48M0.7%00.0%UnchangedHistory
KRYSKrystal Biotech, Inc.COM26,746$4.76M0.8%+1,746+7.0%AddedHistory
SWTXSpringWorks Therapeutics, Inc.COM100,000$4.92M0.8%00.0%UnchangedHistory
FULCFulcrum Therapeutics, Inc.COM550,339$5.20M0.8%+425,339+340.3%AddedHistory
ROIVRoivant Sciences Ltd.SHS500,000$5.27M0.9%00.0%UnchangedHistory
PCVXVaxcyte, Inc.COM80,000$5.46M0.9%+55,000+220.0%AddedHistory
CYTKCytokinetics IncCOM NEW80,000$5.61M0.9%−80,000−50.0%ReducedHistory
SVRASavara IncCOM1,150,000$5.73M0.9%00.0%UnchangedHistory
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$5.78M0.9%–––
ABSIAbsci CorpCOM1,025,000$5.82M0.9%+1,025,000NewHistory
CATXPerspective Therapeutics, Inc.COM5,100,000$6.07M1.0%+5,100,000NewHistory
ELEVElevation Acquisition Group Inc.COM1,268,825$6.51M1.1%+1,268,825NewHistory
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES286,200$6.77M1.1%+161,200+129.0%AddedHistory
Omeros Corp682143AG7NOTE 5.250% 2/1–$7.63M1.2%–––
MORFMorphic Holding, Inc.COM225,000$7.92M1.3%+182,330+427.3%AddedHistory
GERNGeron CorpCOM2,500,000$8.25M1.3%+2,500,000NewHistory
ESTAEstablishment Labs Holdings Inc.COM164,589$8.38M1.4%−63,688−27.9%ReducedHistory
NARIInari Medical, Inc.Stock175,000$8.40M1.4%+155,000+775.0%AddedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS1,027,868$8.55M1.4%+477,868+86.9%AddedHistory
IMVTImmunovant, Inc.COM285,000$9.21M1.5%−60,000−17.4%ReducedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS830,546$9.39M1.5%+34,817+4.4%AddedHistory
Alnylam Pharmaceuticals, Inc.02043QAB3NOTE 1.000% 9/1–$9.45M1.5%–New–
APLSApellis Pharmaceuticals, Inc.COM165,000$9.70M1.6%+90,000+120.0%AddedHistory
AXSMAxsome Therapeutics, Inc.COM139,758$11.2M1.8%+89,758+179.5%AddedHistory
NUVLNuvalent, Inc.COM150,000$11.3M1.8%−25,000−14.3%ReducedHistory
ATXSAstria Therapeutics, Inc.COM845,606$11.9M1.9%−620,859−42.3%ReducedHistory
NRIXNurix Therapeutics, Inc.COM810,253$11.9M1.9%+120,141+17.4%AddedHistory
CERECerevel Therapeutics Holdings, Inc.COM300,000$12.7M2.1%−450,000−60.0%ReducedHistory
ONCBeOne Medicines Ltd.ADR82,143$12.8M2.1%+82,143NewHistory
VRNAVerona Pharma plcSPONSORED ADS817,833$13.2M2.1%+254,009+45.1%AddedHistory
SYRESpyre Therapeutics, Inc.COM NEW410,000$15.6M2.5%−107,554−20.8%ReducedHistory
KURAKura Oncology, Inc.COM730,492$15.6M2.5%+538,957+281.4%AddedHistory
BridgeBio Pharma, Inc.10806XAB8NOTE 2.500% 3/1–$18.3M3.0%–––
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS1,400,000$19.8M3.2%−500,000−26.3%ReducedHistory
INZYInozyme Pharma, Inc.COM2,642,519$20.2M3.3%+756,717+40.1%AddedHistory
VERAVera Therapeutics, Inc.CL A470,000$20.3M3.3%+470,000NewHistory
ACLXArcellx, Inc.COMMON STOCK300,000$20.9M3.4%−40,000−11.8%ReducedHistory
CLDXCelldex Therapeutics, Inc.COM NEW510,000$21.4M3.5%+110,000+27.5%AddedHistory
AUTLAutolus Therapeutics plcSPON ADS3,375,000$21.5M3.5%+1,824,592+117.7%AddedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM470,000$22.0M3.6%+22,905+5.1%AddedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM115,000$30.7M5.0%+15,000+15.0%AddedHistory
XENEXenon Pharmaceuticals Inc.COM837,387$36.0M5.9%+377,387+82.0%AddedHistory
APGEApogee Therapeutics, Inc.COM592,093$39.3M6.4%+55,000+10.2%AddedHistory

Options (17)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Affinity Asset Advisors, LLC in Q1 2024
SecurityClassPutsCalls
State Street SPDR S&P Biotech ETF78464A870ETF$66.4M–
MRNAModerna, Inc.Stock$42.6M–
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS–$23.4M
IRWDIronwood Pharmaceuticals IncCOM CL A–$8.97M
BBIOBridgeBio Pharma, Inc.COM–$7.73M
GRTSGritstone bio, Inc.COM$6.14M–
ALNYAlnylam Pharmaceuticals, Inc.COM–$5.98M
RAPTRAPT Therapeutics, Inc.COM$5.18M$538.8K
GHGuardant Health, Inc.COM–$5.16M
IMVTImmunovant, Inc.COM–$4.67M
CRSPCRISPR Therapeutics AGNAMEN AKT–$4.43M
IBRXImmunityBio, Inc.COM$3.17M–
FULCFulcrum Therapeutics, Inc.COM–$2.60M
ESTAEstablishment Labs Holdings Inc.COM–$2.54M
AKROAkero Therapeutics, Inc.COM–$1.89M
ANVSAnnovis Bio, Inc.COM$867.5K–
CBIOCrescent Biopharma, Inc.COM$426.9K–

Sold out since Q4 2023 (21)

Positions held at the end of Q4 2023 that are gone from this filing.

Positions of Affinity Asset Advisors, LLC sold out since Q4 2023
SecurityClassShares in Q4 2023Value in Q4 2023% of portfolio in Q4 2023History
IMGNImmunoGen, Inc.COM1,404,608$41.6M8.3%History
CBAYCymaBay Therapeutics, Inc.COM1,090,441$25.8M5.1%History
LIANYLianBioSPONSORED ADS3,779,694$16.9M3.4%History
MRTXMirati Therapeutics, Inc.COM100,049$5.88M1.2%History
DVAXDynavax Technologies CorpCOM NEW300,000$4.19M0.8%History
AZNAstraZeneca PLCSPONSORED ADR60,000$4.04M0.8%History
RLAYRelay Therapeutics, Inc.COM300,000$3.30M0.7%History
ARGXArgenx SESPONSORED ADR7,500$2.85M0.6%History
EYPTEyePoint, Inc.COM NEW109,900$2.54M0.5%History
ASNDAscendis Pharma A/SSPONSORED ADR20,000$2.52M0.5%History
PENPenumbra IncCOM7,500$1.89M0.4%History
ADCTADC Therapeutics SASHS1,013,540$1.68M0.3%History
KALVKalVista Pharmaceuticals, Inc.COM125,969$1.54M0.3%History
NBIXNeurocrine Biosciences IncStock10,000$1.32M0.3%History
ALLOAllogene Therapeutics, Inc.COM400,000$1.28M0.3%History
VRDNViridian Therapeutics, Inc.COM50,000$1.09M0.2%History
BHVNBiohaven Ltd.COM20,866$893.1K0.2%History
PBYIPuma Biotechnology, Inc.COM202,349$876.2K0.2%History
NUVBNuvation Bio Inc.COM CL A250,000$377.5K0.1%History
IFRXInflaRx N.V.COM200,097$326.2K0.1%History
ARAVAravive, Inc.COM346,511$42.9K<0.1%History